Comparison of Global, G-TL, & Cornell Media

Withdrawn before enrolling · Phase 4

Conditions studied: Infertility

In brief

This is a prospective, randomized clinical trial to compare the Global commercial single step media to 1) G-TL (Vitrolife), 2) Weill Cornell's single step and sequential steps media, which all support human embryo development in the laboratory using the Vitrolife Time-Lapse system. The main goal of the study is to identify the best culture medium for optimal embryo development.

Key facts

Study ID

NCT03687697

Run by

Weill Medical College of Cornell University

People needed

0

Starts

2018-04-01

Expected to finish

2018-05-01

Last updated by the study team

2018-09-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 40 years of age or younger (maternal)
• 65 years of age or younger (paternal)
• 10 or more oocytes
• Fresh or frozen oocytes (including donor)
• Fresh or frozen (including donor) sperm can be used
• ICSI only
• Frozen embryos from this study can be included in the outcome portion of this study.
• PGD and/or PGS patients included

You may not qualify if…

• Patients with less than 10 oocytes
• Co-culture patients

Where it is running

• Center for Reproductive Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.